United States · FDA National Drug Code directory
BYFAVO
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71390-011_4da618a9-2e04-4d75-922b-173d22b4e84c
- Product NDC
- 71390-011
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- remimazolam besylate
- Labeler
- Acacia Pharma, Ltd.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20201006
- Source listing expiry
- 20261231
Source-listed ingredients
- REMIMAZOLAM BESYLATE — 2.5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL in 1 CARTON (71390-011-11) / 8 mL in 1 VIAL (71390-011-00) · 71390-011-11
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →